Table 1.
Sample collection | Tested | Seroconversion (SARS CoV2 Spike IgG)a |
---|---|---|
21–25 days after dose 1 | 96 | 69 (71.9%)b |
21–25 days after dose 2 | 47 | 45 (95.7%)b |
ELISA detection of anti-SPIKE IgG§-SARS-CoV-2 in blood serum.
Displayed are the number of individuals and the percentage of seroconverted among the tested individuals.